scholarly article | Q13442814 |
P356 | DOI | 10.7326/0003-4819-142-3-200502010-00008 |
P698 | PubMed publication ID | 15684206 |
P2093 | author name string | James Young | |
Anil Jain | |||
C Martin Harris | |||
Ashish Atreja | |||
Jon Burns | |||
Meghan Lehmann | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 182-186 | |
P577 | publication date | 2005-02-01 | |
P1433 | published in | Annals of Internal Medicine | Q564416 |
P1476 | title | Responding to the rofecoxib withdrawal crisis: a new model for notifying patients at risk and their health care providers | |
P478 | volume | 142 |
Q37389352 | Ability to generate patient registries among practices with and without electronic health records |
Q38429530 | Benchmarking electronic medical records initiatives in the US: a conceptual model |
Q48545409 | Currents in contemporary bioethics: physicians' duty to inform patients of new medical discoveries: the effect of health information technology |
Q34293754 | Effect of a clinical trial alert system on physician participation in trial recruitment |
Q36608310 | Health information technology will shift the medical care paradigm |
Q34663541 | Primary Care Management of Chronic Kidney Disease |
Q36059964 | Responding rapidly to FDA drug withdrawals: design and application of a new approach for a consumer health website |
Q36539351 | Reviewing the benefits and costs of electronic health records and associated patient safety technologies |
Q39241785 | Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53. |